Curaleaf (OTCMKTS:CURLF – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.17, Zacks reports. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 23.17%.
Curaleaf Stock Up 6.7%
Shares of CURLF stock traded up $0.22 during trading hours on Tuesday, reaching $3.48. The company had a trading volume of 887,638 shares, compared to its average volume of 1,034,855. The company has a market cap of $2.39 billion, a price-to-earnings ratio of -11.60 and a beta of 1.58. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.52 and a quick ratio of 0.76. Curaleaf has a 12 month low of $0.72 and a 12 month high of $5.05. The business has a fifty day simple moving average of $2.50 and a 200-day simple moving average of $2.59.
Curaleaf Company Profile
Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.
Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.
Featured Stories
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.
